Chronic Pain Market Overview for 2024 to 2034

The chronic pain market is expected to grow significantly, reaching US$ 78,186.20 million in 2024. This growth is driven by the increasing prevalence of chronic diseases, the aging population, the need for over-the-counter pain medications, awareness of alternative therapies, and a focus on research and development. Following these dynamics, the market is expected to reach US$ 152,372.7 million by 2034, exhibiting a CAGR of 6.90%.

Chronic Pain Market Dynamics

  • The chronic pain treatment market is estimated to experience substantial growth in the coming years, driven by factors such as the upsurge in the geriatric population, increased government funding for treatment, and the prevalence of chronic health conditions.
  • Pharmacological, non-pharmacological, and occupational therapies are commonly used to treat health conditions in the elderly population, contributing to market growth.
  • Consumers pursue accessible and convenient pain relief possibilities, leading to a demand for OTC pain treatment. The mounting need for over-the-counter medication plays a crucial role in the market’s expansion.
  • Cognizance of the risks of prolonged painkiller use has led to substitute pain relief therapies. Healthcare professionals are exploring non-pharmacological approaches to managing long-lasting pain.
  • The consistent network of small store pharmacies facilitates the distribution of pain recovery solutions. The easy availability of pain relief medications contributes to market growth.
  • The growing geriatric population, increased prevalence of chronic illnesses, and demand for accessible pain relief options are key drivers contributing to the growth of the pain management market.
  • Growing awareness about alternative therapies has led to increasing demand for new and improved pain management options.
  • Advancements in technology are leading to the development of innovative and non-invasive pain management techniques, creating new opportunities for researchers, healthcare professionals, and industries.
Attributes Details
Market Value for 2024 US$ 78,186.20 million
Projected Market Value for 2034 US$ 152,372.7 million
Value-based CAGR of Market for 2024 to 2034 6.90%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Comparative View of Adjacent Markets

Along with the chronic pain market, a comprehensive in-depth analysis has been conducted on two other related markets, namely, the pain therapeutic injectable market and the chronic disease management market.

The market is experiencing substantial growth over the forecast period, owing to the growing prevalence of chronic pain conditions. The pain therapeutic injectable market is estimated to experience significant growth due to the increasing preference of consumers for injectable drugs for pain management compared to oral medications. Additionally, the chronic disease management market is predicted to grow due to the rising incidence of diseases and the need for effective disease management solutions.

Overall, each of these markets presents unique opportunities, and a thorough understanding of their dynamics is crucial for businesses operating in the healthcare sector.

Chronic Pain Market:

Attributes Chronic Pain Market
Value-based CAGR (2024 to 2034) 6.90%
Projected Market Value (2034) US$ 152,372.7 million
Market Trend Opioids are increasingly being utilized to manage chronic neuropathic pain
Growth Factor Number of cases of musculoskeletal ailments is on the rise significantly

Pain Therapeutic Injectable Market:

Attributes Pain Therapeutic Injectable Market
Value-based CAGR (2024 to 2034) 4.5%
Market Trend Shift toward biologic and novel pain-relieving agents in injectable formulations.
Growth Factor Growing demand for minimally invasive injectable pain treatments among geriatric population

Chronic Disease Management Market:

Attributes Chronic Disease Management Market
Value-based CAGR (2024 to 2034) 13.4%
Market Trend Integration of wearable devices and mobile apps for continuous health monitoring
Growth Factor Shift toward value-based care models emphasizing preventive and proactive healthcare.

Category-wise Outlook

The drug segment is gaining significant market share in chronic pain, particularly neuropathic pain, which requires a delicate balance for effective treatment.

OTC Drugs Remain Essential for Long-term Pain Management in Chronic Conditions

The drug segment is projected to dominate pain management, with a market share of 68.90% in 2024.

  • The growing demand for OTC drugs and the presence of well-established retail pharmacies make the drug segment a top product and crucial component of market growth.
  • Drugs like Opioids are highly effective in relieving pain associated with major chronic conditions, making them a leading pharmacological intervention for long-term pain management.
Attributes Details
Top Product Drugs
Market Share (2024) 68.9%

Governing Bodies Backing Tailored Treatments for Neuropathic Pain Conditions Spurs Market Growth

The neuropathic pain segment is projected to experience significant growth, accounting for 28.4% of the market share in 2024. This is driven by the growing demand for pain management solutions for various neuropathic conditions.

  • Neuropathic pain, causing impairment to the nervous system, is intensified by conditions like diabetic neuropathy and chemotherapy-induced peripheral neuropathy, leading to a high demand for effective treatments.
  • The industry's focus on developing treatments tailored to neuropathic pain patients is supported by governing bodies. This is permitting researchers and pharmaceutical companies to advance in neuropathic pain treatment.
Attributes Details
Indication Neuropathic Pain
Market Share (2024) 28.4%
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Country-wise Analysis

North America holds the major market share, with the aging population and high healthcare expenditure, especially in the United States and Canada. This is contributing significantly to the prevalence of chronic health conditions. This results in a robust demand for pain management treatments.

In Europe, countries like Germany, the United Kingdom, and Russia contribute significantly. Regulatory bodies support market growth by approving drugs for chronic pain treatments. There are well-established healthcare systems that ensure accessibility to pain management therapies.

Asia Pacific is expected to be the fastest-growing region. Developments are driven by growing awareness and infrastructure, with urbanization and economic growth also driving the demand for healthcare services, including pain management.

Countries CAGR (2024 to 2034)
Russia 7.00%
United Kingdom 8.40%
Canada 10.80%
Japan 7.80%
Spain 6.30%

Rising Geriatric Population and Chronic Diseases Fuel Russia's Market

The chronic pain market in Russia is expected to grow at a CAGR of 7.00% due to various factors, such as:

  • The rising geriatric population
  • Increasing prevalence of chronic diseases in Russia

The growing number of chronic diseases, such as arthritis, cancer, and diabetes, has led to an augmented demand for pain administration therapies, thereby driving the growth of the market in Russia.

Rising Awareness in Pain Management and Healthcare Innovations Boost Market in the United Kingdom

The chronic pain market in the United Kingdom is experiencing growth at a CAGR of 8.40%, driven by factors such as:

  • Growing awareness about pain management therapies
  • Advancements in healthcare technologies

The advancement in health technologies and an increasing acceptance of pain management therapies have led to an increased demand for pain management drugs and devices, leading to market growth.

Accessible Advanced and Innovative Treatments Propel Canada's Market

Canada’s chronic pain market is expanding at a CAGR of 10.80%. This growth can be attributed to the availability of advanced and innovative treatment options. The accessibility of advanced and innovative treatment options, such as non-opioid pain medications and minimally invasive procedures, is also contributing to market growth.

Non-opioid Cures Drive Growth in Japan's Chronic Pain Treatment Market

Japan’s chronic pain market is expanding with a CAGR of 7.80% due to various factors. One of the main reasons is the aging population in the country, with a large number of elderly people suffering from prolonged pain. Non-opioid pain medication and minimally invasive procedures are contributing to the growth of the market. The rising awareness about the benefits of early diagnosis and treatment of acute pain is encouraging more patients to seek medical help, driving the market growth.

Spain's Chronic Pain Management Market Thrives on Awareness and Effective Treatments

In Spain, the market is expanding with a CAGR of 6.30% due to the rising demand for effective pain management treatments. The population in Spain is more likely to experience chronic pain, which is driving market progression. Additionally, increased awareness among patients about the need for effective pain management is also boosting the market growth in Spain.

Competitive Landscape in the Chronic Pain Market

The market provides a range of products and options for chronic pain management, such as opioids, non-opioid analgesics, and nerve-block therapies. Companies are searching for the emergence of new players like startups to work on developing innovative therapies for pain management. This is a highly competitive market where industries are prioritizing patient safety, efficacy, and affordability, expected to thrive.

  • Eli Lilly and Company and Dickinson and Company are two major players in this market. Eli Lilly is a pharmaceutical company focusing on developing treatments for pain management, among other areas. Recently, the company announced positive results in a Phase 2b study for a chronic pain drug called lasmiditan.
  • Dickinson and Company, on the other hand, is a medical technology company specializing in creating healthcare products and solutions. The company's recent developments include launching a new line of pain management products, such as the BD Alaris System. Overall, both companies are actively working toward improving pain management solutions for patients with chronic pain.

Recent Developments

  • In December 2023, Forever Cheer, a pharmaceutical company with over 10 global patents, chose Hong Kong as the gateway for the global launch of their innovative pain management drugs. By launching its drugs from Hong Kong, the company aims to expand its reach across the world and make a significant impact in the healthcare industry.
  • In August 2023, MOBE and Override, two digital health innovators, partnered to launch a shared savings program for chronic pain management. The program aims to offer a personalized approach to pain treatment and reduce healthcare costs by utilizing data analytics and behavioral health coaching.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Companies

  • Eli Lilly and Company
  • Dickinson and Company
  • Medtronic plc
  • Johnson & Johnson
  • Novartis AG
  • AstraZeneca PLC
  • Becton
  • Bristol-Myers Squibb Company
  • Sanofi

Key Coverage in the Chronic Pain Market Report

  • Pain management industry analysis
  • Chronic pain treatment sector trends
  • Market demand for chronic pain relief
  • Industry growth factors for chronic pain management
  • Market share of chronic pain treatment providers
  • Emerging opportunities in chronic pain sector

Key Segmentation

By Product:

  • Drugs
  • Devices

By Indication:

  • Neuropathic Pain
  • Arthritis Pain
  • Chronic Back Pain
  • Cancer Pain
  • Migraine
  • Fibromyalgia
  • Others

By Application:

  • Musculoskeletal
  • Neuropathy
  • Oncology
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East and Africa (MEA)

Frequently Asked Questions

How Big is the Chronic Pain Market?

The size of the market is estimated to be US$ 78,186.20 million in 2024.

At What Rate is the Chronic Pain Market Expected to Grow?

The market is expected to increase at a CAGR of 6.90% over the forecast period.

What is the Scope of Chronic Pain Management in Canada?

The market is expected to register a CAGR of 10.80% in Canada from 2024 to 2034.

What is the Future Forecast for the Chronic Pain Market?

The market is forecasted to reach a size of US$ 152,372.7 million by 2034.

Who are the Key Companies in the Market?

Eli Lilly and Company, Dickinson and Company, Medtronic plc, Johnson & Johnson, Novartis AG, AstraZeneca PLC, Becton, Bristol-Myers Squibb Company, Sanofi.

What is the Top Product Type for Chronic Pain?

Drugs are the top product type in the market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

    4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2019 to 2023

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2024 to 2034

        5.3.1. Drugs

        5.3.2. Devices

    5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023

    5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2019 to 2023

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2024 to 2034

        6.3.1. Neuropathic Pain

        6.3.2. Arthritis Pain

        6.3.3. Chronic Back Pain

        6.3.4. Cancer Pain

        6.3.5. Migraine

        6.3.6. Fibromyalgia

        6.3.7. Others

    6.4. Y-o-Y Growth Trend Analysis By Indication, 2019 to 2023

    6.5. Absolute $ Opportunity Analysis By Indication, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034

        7.3.1. Musculoskeletal

        7.3.2. Neuropathy

        7.3.3. Oncology

        7.3.4. Others

    7.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023

    7.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2019 to 2023

    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2024 to 2034

        8.3.1. Hospital Pharmacies

        8.3.2. Retail Pharmacies

        8.3.3. Online Pharmacies

    8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023

    8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034

9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023

    9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Western Europe

        9.3.4. Eastern Europe

        9.3.5. South Asia and Pacific

        9.3.6. East Asia

        9.3.7. Middle East and Africa

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        10.2.1. By Country

            10.2.1.1. USA

            10.2.1.2. Canada

        10.2.2. By Product

        10.2.3. By Indication

        10.2.4. By Application

        10.2.5. By Distribution Channel

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By Indication

        10.3.4. By Application

        10.3.5. By Distribution Channel

    10.4. Key Takeaways

11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Product

        11.2.3. By Indication

        11.2.4. By Application

        11.2.5. By Distribution Channel

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By Indication

        11.3.4. By Application

        11.3.5. By Distribution Channel

    11.4. Key Takeaways

12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. UK

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Western Europe

        12.2.2. By Product

        12.2.3. By Indication

        12.2.4. By Application

        12.2.5. By Distribution Channel

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By Indication

        12.3.4. By Application

        12.3.5. By Distribution Channel

    12.4. Key Takeaways

13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        13.2.1. By Country

            13.2.1.1. Poland

            13.2.1.2. Russia

            13.2.1.3. Czech Republic

            13.2.1.4. Romania

            13.2.1.5. Rest of Eastern Europe

        13.2.2. By Product

        13.2.3. By Indication

        13.2.4. By Application

        13.2.5. By Distribution Channel

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By Indication

        13.3.4. By Application

        13.3.5. By Distribution Channel

    13.4. Key Takeaways

14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        14.2.1. By Country

            14.2.1.1. India

            14.2.1.2. Bangladesh

            14.2.1.3. Australia

            14.2.1.4. New Zealand

            14.2.1.5. Rest of South Asia and Pacific

        14.2.2. By Product

        14.2.3. By Indication

        14.2.4. By Application

        14.2.5. By Distribution Channel

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By Indication

        14.3.4. By Application

        14.3.5. By Distribution Channel

    14.4. Key Takeaways

15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        15.2.1. By Country

            15.2.1.1. China

            15.2.1.2. Japan

            15.2.1.3. South Korea

        15.2.2. By Product

        15.2.3. By Indication

        15.2.4. By Application

        15.2.5. By Distribution Channel

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product

        15.3.3. By Indication

        15.3.4. By Application

        15.3.5. By Distribution Channel

    15.4. Key Takeaways

16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        16.2.1. By Country

            16.2.1.1. GCC Countries

            16.2.1.2. South Africa

            16.2.1.3. Israel

            16.2.1.4. Rest of MEA

        16.2.2. By Product

        16.2.3. By Indication

        16.2.4. By Application

        16.2.5. By Distribution Channel

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Product

        16.3.3. By Indication

        16.3.4. By Application

        16.3.5. By Distribution Channel

    16.4. Key Takeaways

17. Key Countries Market Analysis

    17.1. USA

        17.1.1. Pricing Analysis

        17.1.2. Market Share Analysis, 2023

            17.1.2.1. By Product

            17.1.2.2. By Indication

            17.1.2.3. By Application

            17.1.2.4. By Distribution Channel

    17.2. Canada

        17.2.1. Pricing Analysis

        17.2.2. Market Share Analysis, 2023

            17.2.2.1. By Product

            17.2.2.2. By Indication

            17.2.2.3. By Application

            17.2.2.4. By Distribution Channel

    17.3. Brazil

        17.3.1. Pricing Analysis

        17.3.2. Market Share Analysis, 2023

            17.3.2.1. By Product

            17.3.2.2. By Indication

            17.3.2.3. By Application

            17.3.2.4. By Distribution Channel

    17.4. Mexico

        17.4.1. Pricing Analysis

        17.4.2. Market Share Analysis, 2023

            17.4.2.1. By Product

            17.4.2.2. By Indication

            17.4.2.3. By Application

            17.4.2.4. By Distribution Channel

    17.5. Germany

        17.5.1. Pricing Analysis

        17.5.2. Market Share Analysis, 2023

            17.5.2.1. By Product

            17.5.2.2. By Indication

            17.5.2.3. By Application

            17.5.2.4. By Distribution Channel

    17.6. UK

        17.6.1. Pricing Analysis

        17.6.2. Market Share Analysis, 2023

            17.6.2.1. By Product

            17.6.2.2. By Indication

            17.6.2.3. By Application

            17.6.2.4. By Distribution Channel

    17.7. France

        17.7.1. Pricing Analysis

        17.7.2. Market Share Analysis, 2023

            17.7.2.1. By Product

            17.7.2.2. By Indication

            17.7.2.3. By Application

            17.7.2.4. By Distribution Channel

    17.8. Spain

        17.8.1. Pricing Analysis

        17.8.2. Market Share Analysis, 2023

            17.8.2.1. By Product

            17.8.2.2. By Indication

            17.8.2.3. By Application

            17.8.2.4. By Distribution Channel

    17.9. Italy

        17.9.1. Pricing Analysis

        17.9.2. Market Share Analysis, 2023

            17.9.2.1. By Product

            17.9.2.2. By Indication

            17.9.2.3. By Application

            17.9.2.4. By Distribution Channel

    17.10. Poland

        17.10.1. Pricing Analysis

        17.10.2. Market Share Analysis, 2023

            17.10.2.1. By Product

            17.10.2.2. By Indication

            17.10.2.3. By Application

            17.10.2.4. By Distribution Channel

    17.11. Russia

        17.11.1. Pricing Analysis

        17.11.2. Market Share Analysis, 2023

            17.11.2.1. By Product

            17.11.2.2. By Indication

            17.11.2.3. By Application

            17.11.2.4. By Distribution Channel

    17.12. Czech Republic

        17.12.1. Pricing Analysis

        17.12.2. Market Share Analysis, 2023

            17.12.2.1. By Product

            17.12.2.2. By Indication

            17.12.2.3. By Application

            17.12.2.4. By Distribution Channel

    17.13. Romania

        17.13.1. Pricing Analysis

        17.13.2. Market Share Analysis, 2023

            17.13.2.1. By Product

            17.13.2.2. By Indication

            17.13.2.3. By Application

            17.13.2.4. By Distribution Channel

    17.14. India

        17.14.1. Pricing Analysis

        17.14.2. Market Share Analysis, 2023

            17.14.2.1. By Product

            17.14.2.2. By Indication

            17.14.2.3. By Application

            17.14.2.4. By Distribution Channel

    17.15. Bangladesh

        17.15.1. Pricing Analysis

        17.15.2. Market Share Analysis, 2023

            17.15.2.1. By Product

            17.15.2.2. By Indication

            17.15.2.3. By Application

            17.15.2.4. By Distribution Channel

    17.16. Australia

        17.16.1. Pricing Analysis

        17.16.2. Market Share Analysis, 2023

            17.16.2.1. By Product

            17.16.2.2. By Indication

            17.16.2.3. By Application

            17.16.2.4. By Distribution Channel

    17.17. New Zealand

        17.17.1. Pricing Analysis

        17.17.2. Market Share Analysis, 2023

            17.17.2.1. By Product

            17.17.2.2. By Indication

            17.17.2.3. By Application

            17.17.2.4. By Distribution Channel

    17.18. China

        17.18.1. Pricing Analysis

        17.18.2. Market Share Analysis, 2023

            17.18.2.1. By Product

            17.18.2.2. By Indication

            17.18.2.3. By Application

            17.18.2.4. By Distribution Channel

    17.19. Japan

        17.19.1. Pricing Analysis

        17.19.2. Market Share Analysis, 2023

            17.19.2.1. By Product

            17.19.2.2. By Indication

            17.19.2.3. By Application

            17.19.2.4. By Distribution Channel

    17.20. South Korea

        17.20.1. Pricing Analysis

        17.20.2. Market Share Analysis, 2023

            17.20.2.1. By Product

            17.20.2.2. By Indication

            17.20.2.3. By Application

            17.20.2.4. By Distribution Channel

    17.21. GCC Countries

        17.21.1. Pricing Analysis

        17.21.2. Market Share Analysis, 2023

            17.21.2.1. By Product

            17.21.2.2. By Indication

            17.21.2.3. By Application

            17.21.2.4. By Distribution Channel

    17.22. South Africa

        17.22.1. Pricing Analysis

        17.22.2. Market Share Analysis, 2023

            17.22.2.1. By Product

            17.22.2.2. By Indication

            17.22.2.3. By Application

            17.22.2.4. By Distribution Channel

    17.23. Israel

        17.23.1. Pricing Analysis

        17.23.2. Market Share Analysis, 2023

            17.23.2.1. By Product

            17.23.2.2. By Indication

            17.23.2.3. By Application

            17.23.2.4. By Distribution Channel

18. Market Structure Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Market Share Analysis of Top Players

        18.3.1. By Regional

        18.3.2. By Product

        18.3.3. By Indication

        18.3.4. By Application

        18.3.5. By Distribution Channel

19. Competition Analysis

    19.1. Competition Deep Dive

        19.1.1. Eli Lilly and Company

            19.1.1.1. Overview

            19.1.1.2. Product Portfolio

            19.1.1.3. Profitability by Market Segments

            19.1.1.4. Sales Footprint

            19.1.1.5. Strategy Overview

                19.1.1.5.1. Marketing Strategy

        19.1.2. Dickinson and Company

            19.1.2.1. Overview

            19.1.2.2. Product Portfolio

            19.1.2.3. Profitability by Market Segments

            19.1.2.4. Sales Footprint

            19.1.2.5. Strategy Overview

                19.1.2.5.1. Marketing Strategy

        19.1.3. Medtronic plc

            19.1.3.1. Overview

            19.1.3.2. Product Portfolio

            19.1.3.3. Profitability by Market Segments

            19.1.3.4. Sales Footprint

            19.1.3.5. Strategy Overview

                19.1.3.5.1. Marketing Strategy

        19.1.4. Johnson & Johnson

            19.1.4.1. Overview

            19.1.4.2. Product Portfolio

            19.1.4.3. Profitability by Market Segments

            19.1.4.4. Sales Footprint

            19.1.4.5. Strategy Overview

                19.1.4.5.1. Marketing Strategy

        19.1.5. Novartis AG

            19.1.5.1. Overview

            19.1.5.2. Product Portfolio

            19.1.5.3. Profitability by Market Segments

            19.1.5.4. Sales Footprint

            19.1.5.5. Strategy Overview

                19.1.5.5.1. Marketing Strategy

        19.1.6. AstraZeneca PLC

            19.1.6.1. Overview

            19.1.6.2. Product Portfolio

            19.1.6.3. Profitability by Market Segments

            19.1.6.4. Sales Footprint

            19.1.6.5. Strategy Overview

                19.1.6.5.1. Marketing Strategy

        19.1.7. Becton

            19.1.7.1. Overview

            19.1.7.2. Product Portfolio

            19.1.7.3. Profitability by Market Segments

            19.1.7.4. Sales Footprint

            19.1.7.5. Strategy Overview

                19.1.7.5.1. Marketing Strategy

        19.1.8. Bristol-Myers Squibb Company

            19.1.8.1. Overview

            19.1.8.2. Product Portfolio

            19.1.8.3. Profitability by Market Segments

            19.1.8.4. Sales Footprint

            19.1.8.5. Strategy Overview

                19.1.8.5.1. Marketing Strategy

        19.1.9. Sanofi

            19.1.9.1. Overview

            19.1.9.2. Product Portfolio

            19.1.9.3. Profitability by Market Segments

            19.1.9.4. Sales Footprint

            19.1.9.5. Strategy Overview

                19.1.9.5.1. Marketing Strategy

20. Assumptions & Acronyms Used

21. Research Methodology

Recommendations

Healthcare

Over-the-Counter Pain Medication Market

March 2022

REP-GB-8947

March 2024

333 pages

Healthcare

Pain Therapeutic Injectables Market

April 2023

REP-GB-17090

425 pages

Healthcare

Painkillers Market

April 2023

REP-GB-17075

597 pages

Healthcare

Chronic Disease Management Market

November 2017

REP-GB-5370

July 2022

324 pages

Explore Healthcare Insights

View Reports